26 results
10-K
2022 FY
OBSVF
ObsEva SA
31 Mar 23
Annual report
4:01pm
treatment-related side effects could impede subject recruitment and clinical trial enrollment or the ability of enrolled patients to complete the trial … external vendor, or contract research organization (CRO), manages the logistics of patient recruitment, randomization, and follow-up within
6-K
EX-99.2
eogng41i3x4 7u
6 Aug 20
Index to Unaudited Condensed Consolidated Financial Statements
6:53am
6-K
EX-99.2
5x4fou3 ixexwowws182
5 May 20
Index to Unaudited Condensed Consolidated Financial Statements
6:01am
6-K
3s2r73h3h8xk2
13 Nov 19
Index to Unaudited Condensed Consolidated Financial Statements
4:00pm
6-K
EX-99.2
89zxhz 4bqdy9deberl4
13 Nov 19
Index to Unaudited Condensed Consolidated Financial Statements
4:00pm
6-K
EX-99.1
hdg00id yhi
7 Aug 19
Current report (foreign)
7:21am
6-K
EX-99.3
fp1pa
7 Aug 19
Index to Unaudited Condensed Consolidated Financial Statements
6:04am
6-K
EX-99.2
rs5rgmo
7 Aug 19
Index to Unaudited Condensed Consolidated Financial Statements
6:04am
6-K
2myqs gc6rcqs6jcx
19 Jun 19
Current report (foreign)
4:30pm
6-K
EX-99.2
j6wjj 2wyggakre
9 May 19
Index to Unaudited Condensed Consolidated Financial Statements
6:05am
6-K
EX-99.3
20uul1
9 May 19
Index to Unaudited Condensed Consolidated Financial Statements
6:05am
6-K
EX-99.2
pdberfcwp2cy1xk7hgop
18 Jun 18
ObsEva SA Achieves Primary and Secondary Endpoints for EDELWEISS
9:17am
6-K
EX-99.2
9replq2kmm1 putcnntk
16 May 18
Index to Unaudited Consolidated Interim Financial Statements
4:56pm
6-K
EX-99.1
u3w5a5 mi4po
30 Mar 18
Current report (foreign)
12:00am